← Open Payments lookup

ROBBIN MULINA: Open Payments

NPI 1992154900 · HOUMA, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,773 in 88 payments from 13 companies in 2025. Trend: 2023 $1,233 · 2024 $1,848 · 2025 $1,773

Food & beverage: $1,772Education: $1
CompanyPaymentsAmount
Supernus Pharmaceuticals, Inc.10$327
Otsuka America Pharmaceutical, Inc.16$292
ABBVIE INC.15$234
E.R. Squibb & Sons, L.L.C.13$186
Vanda Pharmaceuticals Inc.8$174
Janssen Pharmaceuticals, Inc7$146
Neurocrine BioSciences, Inc.4$117
Teva Pharmaceuticals USA, Inc.4$77
Alkermes, Inc.3$73
Lundbeck LLC4$69

Products named: Qelbree, VRAYLAR, REXULTI, COBENFY, FANAPT, ABILIFY ASIMTUFII, INGREZZA, INVEGA SUSTENNA.

Industry payments across LA — which companies pay providers there.